Pharmaceuticals by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

GSK has the lowest figure of the 14 pharmaceuticals ranked by P/S ratio, at 2.3, followed by Sanofi (2.4) and Bristol-Myers Squibb (2.6). Figures as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
14
Lowest
GSK2.3
Median
5.2
Combined market value
$4.50T
Countries
5

Market values as of .

Pharmaceuticals by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1GSKGSK · Health Care2.3$99.2B$49.48 1.84% down 6% up United Kingdom
2SanofiSNY · Health Care2.4$115.1B$47.94 0.93% down 4% down France
3Bristol-Myers SquibbBMY · Health Care2.6$124.7B$61.00 3.07% down 34% up United States
4PfizerPFE · Health Care2.6$162.8B$28.57 1.00% down 13% up United States
5Novo NordiskNVO · Health Care3.9$179.2B$40.67 2.25% down 13% down Denmark
6Abbott LaboratoriesABT · Health Care4.1$183.9B$106.20 1.16% down 17% down United States
7AstraZenecaAZN · Health Care4.8$284.4B$183.35 0.36% down 3% up United Kingdom
8Merck & CoMRK · Health Care5.5$355.3B$144.11 0.24% down 50% up United States
9NovartisNVS · Health Care5.5$302.1B$159.94 0.17% down 25% up Switzerland
10Regeneron PharmaceuticalsREGN · Health Care6.9$99.6B$962.50 1.06% up 31% up United States
11Johnson & JohnsonJNJ · Health Care7.2$675.9B$280.77 0.63% down 41% up United States
12AbbVieABBV · Health Care8.5$519.2B$293.73 0.28% down 26% up United States
13Vertex PharmaceuticalsVRTX · Health Care11.3$135.4B$534.15 0.68% down 23% up United States
14Eli LillyLLY · Health Care19.4$1.26T$1,416.63 1.05% down 39% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report.

Questions and answers

Which pharmaceuticals have the lowest P/S ratio?

GSK (2.3), Sanofi (2.4) and Bristol-Myers Squibb (2.6) have the lowest P/S ratio of the 14 pharmaceuticals ranked here as of 17 Nov 2026, 17:16 UTC.

How many pharmaceuticals are in this ranking?

14 are ranked by P/S ratio.

What are these pharmaceuticals worth together?

Their combined market value is $4.50T as of 17 Nov 2026, 17:16 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Pharmaceuticals by P/S ratio”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.